Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Navigation: All Nurses Play a Role

      December 5, 2011
      By Lisa Schulmeister, RN, MN, APRN-BC, OCN, FAAN
      Publication
      Article
      Oncology Nursing NewsNovember 2011
      Volume 5
      Issue 7

      Navigation programs in healthcare facilities are proliferating. However, there is considerable variability in their scope and implementation.

      Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN

      Editor-in-Chief OncLive Nursing

      Oncology Nursing Consultant, Adjunct Assistant Professor of Nursing Louisiana State Health Sciences Center in New Orleans, Louisiana

      This month’s OncLive Nursing features coverage of the National Coalition of Oncology Nurse Navigators (NCONN) 3rd Annual Changing the Face of Cancer Care Conference. The emergence and success of NCONN is a testament to the rapid growth of nurse navigation as a subspecialty of oncology nursing. As an introduction to our NCONN coverage, here is some background information on nurse navigation, with an emphasis on the important role all nurses can play in navigating patients across the cancer care continuum.

      Harold P. Freeman, MD, FACS, founded patient navigation in Harlem, New York, in 1990. As a breast cancer surgeon, he was regularly seeing patients with late-stage cancer who had severely limited treatment options. His orginal focus for patient navigation was to increase the rates of early screening and diagnosis to ensure patients were presenting at earlier stages, when the options for improving survival and quality of life are far greater. In the decades since Freeman originated the concept, navigation has evolved to increasingly focus on guiding patients through the entire cancer care continuum.

      NCONN now defines the oncology nurse navigator (ONN) as “a professional whose clinical nursing expertise guides patients, families, and their caregivers to informed decision-making, collaborating with a multidisciplinary team to allow for timely cancer screening, diagnosis, treatment, and increased supportive care across the cancer continuum.” ONNs either guide a general population of patients with cancer, or guide a subpopulation of patients (eg, breast care navigators).

      Navigation programs in healthcare facilities are proliferating. However, there is considerable variability in their scope and implementation. Navigation programs are informal in some facilities, while in others they are specialized and have dedicated staff. The Commission on Cancer (CoC) of the American College of Surgeons notes that the variability in navigation services offered at a particular facility can depend on the type, severity, and complexity of identified barriers to accessing cancer care. Examples of frequently encountered barriers that have the potential to be reduced or eliminated through patient navigation include financial barriers, communication barriers, fragmented care, and emotional distress.

      The CoC is in the process of phasing in standard 3.1, the Patient Navigation Process, as a component of its accreditation standards (the standard is to be fully implemented by 2015). The standard requires that accredited centers have navigation programs. Specifically, “A patient navigation process, driven by a community needs assessment, is established to address health care disparities and barriers to care for patients. Resources to address identified barriers may be provided either on-site or by referral to community-based or national organizations.”

      “

      A seamless journey is certainly a better outcome than a rocky road of care, and all nurses can promote a seamless journey. ”

      The addition of the new standard addresses the tremendous need to add navigation programs in many parts of the United States. In several areas of the country, navigation programs need to be created to address cancer health disparities identified in the community and incorporate processes that involve collaboration with community-based organizations.

      Information on creating and implementing navigation programs is available from NCONN, the Association of Community Cancer Care Centers, the Harold P. Freeman Patient Navigation Institute, and the National Cancer Institute Center to Reduce Health Disparities Patient Navigator Research Program.

      Nurse navigation helps ensure that patients with cancer have a seamless journey from the time of diagnosis to survivorship or end-of-life. A seamless journey is certainly a better outcome than a rocky road of care, and all nurses can promote a seamless journey. If there is a navigation program in your facility, or one nearby that your patients are eligible to participate in, refer patients to these programs. If navigation programs or services are not available in your area, conduct a community needs assessment, identify healthcare system barriers, and implement needed navigation services. If you’re already in a nurse navigator role, collect data on outcome measures and share information on your models of care.

      Navigation is an essential component of cancer care and has demonstrated efficacy as a strategy to reduce cancer mortality. Navigation is currently also being applied to reduce mortality in other chronic diseases, so its utilization is further expanding. Hopefully, all patients with 1 or more chronic diseases will soon have access to navigation services and programs.

      Articles in this issue

      Psychosocial Considerations in Cancer Care
      Osteonecrosis of the Jaw Related to Antiresorptive Therapy
      Oncofertility: Updates on Fertility Preservation Related to Cancer Care
      Breast Cancer Treatment Update
      Clinical Management of Primary Brain Tumors
      3rd Annual NCONN Conference: Including insights from Harold P. Freeman, MD, FACS, the founder of patient navigation
      Lynch Syndrome International
      What is the best way to administer bendamustine, since some clinicians classify it as an irritant and others classify it as a vesicant?
      Assessment Comes First in Navigating Young Adults With Cancer
      Navigation: All Nurses Play a Role

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman with her hair in a ponytail in front of a light blue background
      Image of a woman with gray hair on a light blue background
      Photo of a man wearing scrubs in front of a blue background
      Related Content

      Graphic of myeloma cells

      Q&A: Subcutaneous Daratumumab Eases Myeloma Time Burden

      Bridget Hoyt
      June 25th 2025
      Article

      Subcutaneous daratumumab makes it easier for patients to find appointments that fit with their lifestyles and schedules, according to Gina Fries, PA-C.


      Magazine page with Rx Road Map for Durvalumab for Non-Small Cell Lung Cancer

      Rx Road Map: Durvalumab for Non-Small Cell Lung Cancer

      Stacey Hield, BSN, RN, OCN
      June 19th 2025
      Article

      Read Stacey Hield, BSN, RN, OCN's recommendations for the best use of durvalumab in non–small cell lung cancer.


      Photo of two women smiling with their arms around each other, one with a headwrap

      No One Should Face Cancer Alone: The Power of Community in Cancer Care

      Marissa Fors LCSW, OSW-C, CCM
      June 18th 2025
      Article

      Ask patients, "Who's in your corner?"


      Photo of a nurse recording data on a computer and tablet

      The Evolving Role of the Oncology Nurse in Clinical Trials

      Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN
      June 14th 2025
      Article

      Oncology nurses are paramount to the treatment success of patients, especially through their work on clinical trials.


      Photo of an APP talking to and empowering a patient

      Case Study: Bridging the Gap for Patients With Metastatic CRC

      Randi Kihnel, MSN, APRN, ACCNS-AG
      June 13th 2025
      Article

      Advanced practice providers have the opportunity to instill hope in patients through education and personalized care.


      PDF of Rx Road Map for subcutaneous daratumumab in multiple myeloma

      Rx Road Map: Subcutaneous Daratumumab in Multiple Myeloma

      Sylwia Zielinska, RN
      Published: May 7th 2025 | Updated: June 5th 2025
      Article

      A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.

      Related Content

      Graphic of myeloma cells

      Q&A: Subcutaneous Daratumumab Eases Myeloma Time Burden

      Bridget Hoyt
      June 25th 2025
      Article

      Subcutaneous daratumumab makes it easier for patients to find appointments that fit with their lifestyles and schedules, according to Gina Fries, PA-C.


      Magazine page with Rx Road Map for Durvalumab for Non-Small Cell Lung Cancer

      Rx Road Map: Durvalumab for Non-Small Cell Lung Cancer

      Stacey Hield, BSN, RN, OCN
      June 19th 2025
      Article

      Read Stacey Hield, BSN, RN, OCN's recommendations for the best use of durvalumab in non–small cell lung cancer.


      Photo of two women smiling with their arms around each other, one with a headwrap

      No One Should Face Cancer Alone: The Power of Community in Cancer Care

      Marissa Fors LCSW, OSW-C, CCM
      June 18th 2025
      Article

      Ask patients, "Who's in your corner?"


      Photo of a nurse recording data on a computer and tablet

      The Evolving Role of the Oncology Nurse in Clinical Trials

      Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN
      June 14th 2025
      Article

      Oncology nurses are paramount to the treatment success of patients, especially through their work on clinical trials.


      Photo of an APP talking to and empowering a patient

      Case Study: Bridging the Gap for Patients With Metastatic CRC

      Randi Kihnel, MSN, APRN, ACCNS-AG
      June 13th 2025
      Article

      Advanced practice providers have the opportunity to instill hope in patients through education and personalized care.


      PDF of Rx Road Map for subcutaneous daratumumab in multiple myeloma

      Rx Road Map: Subcutaneous Daratumumab in Multiple Myeloma

      Sylwia Zielinska, RN
      Published: May 7th 2025 | Updated: June 5th 2025
      Article

      A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.

      Latest Conference Coverage

      Understanding How On-Target and Off-Target ADC Toxicities Work

      Monitoring for Infection-Like AEs Is Essential for CIML NK in GI Cancers

      Belzutifan May Lengthen Quality-Adjusted Survival in Advanced RCC

      KIM-1 Biomarker May Be Prognostic of Response, Outcomes in RCC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.